SCHEMBL3848664

SCHEMBL3848664

Cc1cc(-c2cn(C(c3ccccc3)(c3ccccc3)c3ccccc3)nc2-c2ccc(F)cc2)cn2c(I)cnc12

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.32
CSNK1D P48730 3/20 0.32
CSNK1E P49674 3/20 0.32
MAPK14 Q16539 3/20 0.32
MAPK13 O15264 2/20 0.32
MAPK12 P53778 2/20 0.32
MAPK11 Q15759 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
IDO1 P14902 1/20 0.31
KCNH2 Q12809 1/20 0.31
SRC P12931 1/20 0.30
BRAF P15056 1/20 0.30
KDR P35968 1/20 0.30
STAT1 P42224 1/20 0.30
CDK1 P06493 1/20 0.30
CDK4 P11802 1/20 0.30
CCNB1 P14635 1/20 0.30
CCNA2 P20248 1/20 0.30
CCND1 P24385 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847945 0.90 SMN1; SMN2 (0.34) PTGS2CSNK1DCSNK1EMAPK14MAPK13
SCHEMBL3846334 0.89 SMN1; SMN2 (0.39) PTGS2CSNK1DCSNK1EMAPK14MAPK13
SCHEMBL3845976 0.83 TGFBR1 (0.40) MAPK14
SCHEMBL3848665 0.83
SCHEMBL3847154 0.82 KDR (0.37) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL3846676 0.80 ADORA2A (0.36) PTGS2CSNK1DCSNK1EMAPK14MAPK13
SCHEMBL3845235 0.79 SMN1; SMN2 (0.34) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL3847277 0.73 SMN1; SMN2 (0.36) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL3847948 0.73
SCHEMBL3850256 0.73 FLT3 (0.34) PTGS2CSNK1DCSNK1EMAPK14MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed